The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones.

OBJECTIVE The purpose of this study was to assess the effect of 17 beta-estradiol, progesterone, and testosterone on secretion of plasminogen activators and plasminogen activator inhibitor type 1 by cultured endothelial cells. STUDY DESIGN Bovine aortic endothelial cells were cultured in medium that contained 17 beta-estradiol, progesterone, or testosterone at various concentrations (10(-13) to 10(-6) mol/L). Plasminogen activator activity in culture medium in the presence of cells was assayed after a 36-hour incubation using chromogenic substrate and iodine 125-labeled fibrin plate assays. Plasminogen activator inhibitor type 1 antigen was detected in conditioned media of bovine aortic endothelial cells by Western blotting analysis. RESULTS All three steroid hormones exhibited biphasic dose-response effects, characterized by stimulation of plasminogen activator secretion at lower concentrations and inhibition of plasminogen activator secretion at higher concentrations. A significant stimulatory effect on plasminogen activator secretion (74% over control) was observed at a 17 beta-estradiol concentration of 10(-12) mol/L (p < 0.03). At higher concentrations of 17 beta-estradiol, progesterone, and testosterone, inhibition of plasminogen activator secretion was observed (p < 0.05). Decreased levels of plasminogen activator inhibitor type 1 antigen were detected in supernatants treated with either 17 beta-estradiol or progesterone at a concentration of 10(-12) mol/L and were maximal at 10(-7) mol/L 17 beta-estradiol, progesterone, and testosterone. CONCLUSION The secretion of plasminogen activators and plasminogen activator inhibitor type 1 is regulated in a biphasic dose-dependent manner by sex hormones in bovine aortic endothelial cells.

[1]  T. Bjornsson,et al.  Role of polyamines in the stimulation of synthesis and secretion of plasminogen activator from bovine aortic endothelial cells , 1988, Journal of cellular physiology.

[2]  S. Pizzo,et al.  Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor. , 1987, American journal of obstetrics and gynecology.

[3]  M. Dougherty,et al.  Menopausal status associated with increased inhibition of blood coagulation. , 1981, American journal of obstetrics and gynecology.

[4]  D. Loskutoff,et al.  Fibrinolytic System of Vascular Endothelial Cells , 1988 .

[5]  B. Wiman,et al.  Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.

[6]  E. Barrett-Connor,et al.  Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. , 1983, JAMA.

[7]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[8]  W. Laug.  Glucocorticoids Inhibit Plasminogen Activator Production by Endothelial Cells , 1983, Thrombosis and Haemostasis.

[9]  P. Colburn,et al.  Estrogen-binding sites in endothelial cell cultures , 1978 .

[10]  N. Dreyer,et al.  Blood coagulation and idiopathic thromboembolism among fertile women. , 1980, Contraception.

[11]  M. Sawdey.  EXPRESSION IN CULTURED ENDOTHELIAL CELLS AND THE VESSEL WALL , 1991 .

[12]  C. Christiansen,et al.  Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. , 1991, The Journal of clinical investigation.

[13]  C. Dempfle,et al.  Purification of human plasma fibrinogen by chromatography on protamine-agarose. , 1987, Thrombosis research.

[14]  O. Ylikorkala,et al.  Regulation of prostacyclin and thromboxane production by human umbilical vessels: the effect of estradiol and progesterone in a superfusion model. , 1982, Prostaglandins, leukotrienes, and medicine.

[15]  M. Alessi,et al.  Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis , 1987, Thrombosis and Haemostasis.

[16]  H. Mcgill,et al.  Nuclear Uptake of Sex Steroid Hormones in the Cardiovascular System of the Baboon , 1981, Circulation research.

[17]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[18]  S. Pizzo,et al.  Physical conditioning augments the fibrinolytic response to venous occlusion in healthy adults. , 1980, The New England journal of medicine.

[19]  Gene regulation by steroid hormones , 1989, Cell.

[20]  H. S. Klopfenstein,et al.  Estrogen modulates responses of atherosclerotic coronary arteries. , 1990, Circulation.

[21]  C. Shively,et al.  Oral Contraceptives and Coronary Artery Atherosclerosis of Cynomolgus Monkeys , 1990, Obstetrics and Gynecology.